BENICAR HCT 40-12.5 MG TABLET

olmesartan medoxomil-hydrochlorothiazide
$15.6518per EA

Strength

12.5; 40 mg/1; mg/1

NDC

00713086430

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021532

On Market Since

9/1/2022

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+0.1%

3M

+10.1%

6M

+10.1%

1Y

+10.3%

3Y

+32.4%

5Y

N/A

All

+32.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.